| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/RAVV-8NM1-CJB7-GJFR |
| P698 | PubMed publication ID | 11068545 |
| P2093 | author name string | Ito Y | |
| Noda K | |||
| Monden M | |||
| Sakon M | |||
| Matsuura N | |||
| Miyoshi E | |||
| Taniguchi N | |||
| Tsujimoto M | |||
| Takeda T | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 719-725 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Expression and possible role of ets-1 in hepatocellular carcinoma | |
| P478 | volume | 114 |
| Q38313479 | COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer |
| Q78366099 | Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers |
| Q28203828 | EAPII interacts with ETS1 and modulates its transcriptional function |
| Q44097865 | Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes. |
| Q34786517 | Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma |
| Q35692510 | MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1. |
| Q43851747 | Serum protein N-glycan alterations of diethylnitrosamine-induced hepatocellular carcinoma mice and their evolution after inhibition of the placental growth factor |
| Q47159298 | The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury. |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q92787270 | WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 |
| Q61810936 | miRNA-20b inhibits cerebral ischemia-induced inflammation through targeting NLRP3 |
Search more.